noticed the same thing. We already have ovarian preclinicals which were good but market opportunity was indifferent, but now adding cardio protect that turns the table. Still of the view FTO trial will be a separate showcase based on the 100+ review.
General Comments / Chat, page-7500
-
- There are more pages in this discussion • 3,981 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
0.050(3.08%) |
Mkt cap ! $285.4M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.64 | $210.4K | 125.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 595 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |